Analysts on Monday said Amazon is a “potential gold mine” for pharmaceutical companies and the company’s stock price could double to $500 a share in the next year.But that isn’t necessarily a bad thing, said Neil Zacks, president of Zacks & Associates in New York.“Amazon could very well be a real gold mine for pharma, […]

Continue Reading...